New data shows that an experimental inhaled insulin drug called Exubera is effective in controlling blood sugar levels in diabetics over prolonged periods of time.
Read More »Low Chromium Linked to Heart Disease Risk in Patients With Diabetes
Low chromium levels as measured in toenail clippings are associated with an increased risk of cardiovascular disease (CVD) for patients with diabetes.
Read More »A Daily Walk Prevents Diabetes By As Much As 80%
Ten Year study shows that just a half an hour’s walking a day can almost eradicate the risk of developing diabetes.
Read More »Statin Use In Type 2 Diabetes Can Delay Initiation Of Insulin
Statin use was associated with a 10-month delay before newly treated diabetic subjects needed to start insulin treatment.
Read More »New Imaging Technology Detects Early Signs of Type 1 Diabetes
New technology gives scientists a glimpse into the earliest stages of the inflammatory process leading to type 1 diabetes and the new findings one day may be useful for predicting whether and when diabetes will develop in humans.
Read More »Exenatide New Drug Application Accepted by the FDA
First potential therapy in a new class of drugs under investigation for the treatment of type 2 diabetes known as incretin mimetics.
Read More »New Report Maps Women’s Health in the United States Shows Patterns by State for
West Virginia, Ohio and Vermont have the Highest Death Rate for Diabetes in White Females and West Virgina, North Carolina and South Carolina have the Highest Death rate for Black Females. Hawaii has the lowest overall death rate for women, Colorado the lowest rate of obesity, and Minnesota ranks best …
Read More »Blueberries Fights Heart Disease, Cancer and Diabetes
They have potential to lower cholesterol as effectively as commercial drugs. Blueberries, already known to help fight cancer and diabetes, may guard against heart disease as well.
Read More »Help Is On The Way For Loosing Wt. And Smoking Cessation
First year results of the two year trial Rimonabant In Obesity (RIO, a Phase III clinical study, showed a 3.5 inch reduction in waist circumference, 19 pounds lost, reduced metabolic syndrome 50%, raised HDL 28%. Rimonabant (endocannabinoid) in another study doubled the odds of quitting smoking without weight gain.
Read More »Global Study Shows Nine Factors Identify 90% Of Heart Attack Risk
The vast majority of heart attacks can be predicted by nine easily measurable factors, that are the same in every region and ethnic group worldwide
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.